French pharma giant Sanofi (SNYNF) says its COVID-19 vaccine will cost under €10, and has also announced its intention to take its active pharmaceutical …
French drugmaker Sanofi and GlaxoSmithKline announced the start of the Phase 1/2 human clinical trial for their adjuvanted protein-based COVID-19 vaccine. Sanofi (SNYNF) …
French drugmaker Sanofi announced Tuesday that a late-stage study of the rheumatoid arthritis drug Kevzara tested in severely or critically ill patients hospitalized with …
French drugmaker Sanofi announced Monday that it entered into an agreement to acquire US company Principia Biopharma in an all-stock deal valued at …
Sanofi (SNYNF) and and GlaxoSmithKline (GSK) are in advanced discussions with the European Commission (EC) for the supply of up to 300 million …
Sanofi (SNYNF) and GSK (GSK) have now confirmed an agreement with the UK government for the supply of up to 60 million doses …
Sanofi (SNY) and Translate Bio (TBIO) have announced that they are expanding their existing 2018 collaboration and license agreement to develop mRNA vaccines …
French drugmaker Sanofi (SNYNF) has received regulatory approval in China for its Dupixent drug, which it is developing together with Regeneron Pharmaceuticals, Inc …
French drugmaker Sanofi (SNYNF) said it is exploring additional growth opportunities for its Dupixent drug, which it is developing together with Regeneron Pharmaceuticals, …
Shares in Translate Bio (TBIO) surged 24% on Friday, after Sanofi (SNYNF) made several positive comments about the outlook for their joint coronavirus …
